Filing Flows

Filing Flows › Companies › Omada Health › Cash flow

Omada Health cash flow, quarter by quarter

Latest: Q3 2026 · from the cash-flow statements filed with the SEC

Free cash flow$15.0M in Q3 2026 · $28.2M over twelve months

Operating cash flow$15.1M
Capital spending−$118K
Free cash flow+$15.0M
Cash / net income2.3×
Cash conversion cycle29 days

Analysis

In Q3 2026, Omada Health generated $15.1M of operating cash flow and spent $118K on capital projects, leaving free cash flow of $15.0M. That is $5.4M more than in Q3 2025 ($9.6M).

Over the twelve months to Sep 30, 2026, operating cash flow was $28.7M; the largest uses were other investing ($5.7M), other financing ($1.3M), capital spending ($541K); besides operations, cash came from shares issued ($23.4M); the cash balance rose by $44.5M.

Operating cash flow was $15.1M against net income of $6.6M — 2.3× profit, cash ran ahead of reported earnings. The largest differences: receivables +$7.3M, prepaid and other assets −$6.3M, stock-based pay +$5.9M.

Its cash conversion cycle was 29 days (receivables 53 + inventory 19 − payables 42).

Free cash flow

Omada Health: free cash flow by quarterOmada Health: free cash flow by quarter−$6.7MQ4 2024−$16.4MQ1 2025$2.6MQ2 2025$9.6MQ3 2025$21.2MQ4 2025−$11.9MQ1 2026$3.9MQ2 2026$15.0MQ3 2026
Operating cash flow less capital spending.
Omada Health: operating cash flow against capital spendingOmada Health: operating cash flow against capital spendingOperating cash flowCapital spending−$6.5M$184KQ4 2024−$16.1M$315KQ1 2025$2.9M$271KQ2 2025$10.1M$537KQ3 2025$21.4M$199KQ4 2025−$11.8M$78KQ1 2026$4.0M$146KQ2 2026$15.1M$118KQ3 2026
Latest (Q3 2026): Operating cash flow $15.1M, Capital spending $118K.

Capital allocation, year by year

Omada Health: where the cash came from (up) and went (down), by fiscal yearOmada Health: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedCapital spendingFY2023: Operating cash flow −$49.7MFY2023: Net borrowing $31.0MFY2023: Shares issued $1.8MFY2023: Capital spending −$416K$32.7MFY2023FY2024: Operating cash flow −$34.2MFY2024: Shares issued $3.3MFY2024: Capital spending −$596K$3.3MFY2024FY2025: Operating cash flow $18.3MFY2025: Shares issued $170MFY2025: Capital spending −$1.3M$188MFY2025
Over these 3 years operating cash flow totalled −$65.7M; the largest uses were operating cash flow ($83.9M) and capital spending ($2.3M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$243M
Debtnone
Net cash$243M

Omada Health funds itself: free cash flow was $28.2M over the last twelve months, with $243M of cash and investments and no debt on the balance sheet.

Where the cash came from and went

Omada Health: sources (+) and uses (−) of cash, Q3 2026Omada Health: sources (+) and uses (−) of cash, Q3 2026Cash drawn (+) / kept (−)−$21.4MOperating cash flow$15.1MShares issued$8.6MOther investing−$1.5MTaxes on employees’ shares−$668KCapital spending−$118K
Omada Health: sources (+) and uses (−) of cash, TTM to Q3 2026Omada Health: sources (+) and uses (−) of cash, TTM to Q3 2026Cash drawn (+) / kept (−)−$44.5MOperating cash flow$28.7MShares issued$23.4MOther investing−$5.7MOther financing−$1.3MCapital spending−$541K

From profit to cash

Omada Health: net income to operating cash flow, Q3 2026Omada Health: net income to operating cash flow, Q3 2026Net income$6.6MDepreciation & amortization$1.7MStock-based pay$5.9MGains on disposals$27KReceivables$7.3MInventory−$761KPayables−$3.6MAccrued liabilities$5.2MDeferred revenue−$1.9MContract assets−$726KPrepaid and other assets−$6.3MOperating cash flow$15.1M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q3 202653194229
Q2 202650153827
Q1 202643132828
Q4 202546163230
Q3 202551132638

Every quarter

QuarterOperating cash flowCapital spendingShares issuedCash drawn (+) / kept (−)Free cash flow
Q3 2026$15.1M−$118K$8.6M−$21.4M$15.0M
Q2 2026$4.0M−$146K$8.1M−$9.9M$3.9M
Q1 2026−$11.8M−$78K$3.2M$10.3M−$11.9M
Q4 2025$21.4M−$199K$3.4M−$23.4M$21.2M
Q3 2025$10.1M−$537K$2.1M$24.5M$9.6M
Q2 2025$2.9M−$271K$3.0M−$164M$2.6M
Q1 2025−$16.1M−$315K$919K$17.0M−$16.4M
Q4 2024−$6.5M−$184K$1.3M$7.3M−$6.7M

Omada Health: income statement and cash flow

Omada Health, Q3 2026: revenue $91.3M (+34% year over year), operating margin 5.3%. The chart follows the revenue to costs, profit and cash.

Omada Health: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.